Home › Biotechnology › Biosimilars
Biosimilars Market Research Report
Biosimilars are new versions of generic pharmaceuticals, introduced in the market following the patent expiry of the latter. Biosimilars may act differently from their predecessors due to differences in molecular structures and preparation methods. The biosimilars market is expected to have a decent growth rate due to the imminent patent expiry of many blockbuster drugs. We track the markets for the major biosimilars drug types, their ingredients, applications, and technologies.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Biosimilars (2009 - 2014)Biosimilars report will provide indepth market assessment, market estimates and forecast, competitive landscape for the series of biosimilars- Erythropoeitins, Granulocyte Colony Stimulating Factors, Market, HGH, Insulin and Analogs, Interferons. Report code- LS00110 |
September 2009 | $ 4650 |
|
Custom Research
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
Search reports
